The International Journal of Tuberculosis and Lung Disease

6 ta ish

Jurnal · ISSN 1027-3719

1. Acquired bedaquiline resistance in Karakalpakstan, Uzbekistan

   Parvati Nair, T. Hasan, K. K. Zaw +9

   MaqolaOAOchiq kirishTuberculosis Research and EpidemiologyThe International Journal of Tuberculosis and Lung Disease20224 iqtibos

   ABIABI:AkademIndex/2026.other.281624

2. ‘They prefer hidden treatment': anti-tuberculosis drug-taking practices and drug regulation in Karakalpakstan

   Beverley Stringer, Karen Lowton, Mirzagaleb N. Tillashaikhov +5

   MaqolaOAOchiq kirishTuberculosis Research and EpidemiologyThe International Journal of Tuberculosis and Lung Disease20162 iqtibos

   ABIABI:AkademIndex/2016.article.000087

3. Primary bedaquiline resistance in Karakalpakstan, Uzbekistan

   S. Moe, M. L. Rekart, D. Hernandez +9

   MaqolaOAOchiq kirishTuberculosis Research and EpidemiologyThe International Journal of Tuberculosis and Lung Disease20232 iqtibos

   ABIABI:AkademIndex/2026.other.281628

4. Ambulatory tuberculosis treatment in post-Semashko health care systems needs supportive financing mechanisms

   Stefan Köhler, Damin Asadov, Andreas Bründer +4

   MaqolaHIV/AIDS Impact and ResponsesThe International Journal of Tuberculosis and Lung Disease20142 iqtibos

   ABIABI:AkademIndex/2026.other.364601

5. Impact of pyrazinamide resistance on multidrug-resistant tuberculosis in Karakalpakstan, Uzbekistan

   Johanna Kuhlin, Chris Smith, Atadjan Khaemraev +8

   MaqolaTuberculosis Research and EpidemiologyThe International Journal of Tuberculosis and Lung Disease20181 iqtibos

   ABIABI:AkademIndex/2018.article.000181

6. Identification of patients who could benefit from bedaquiline or delamanid: a multisite MDR-TB cohort study

   M. Bonnet, Mathieu Bastard, Philipp du Cros +9

   MaqolaTuberculosis Research and EpidemiologyThe International Journal of Tuberculosis and Lung Disease20150 iqtibos

   ABIABI:AkademIndex/2015.article.000040